XML 199 R19.htm IDEA: XBRL DOCUMENT v3.22.4
Results for the Year (Details) - DKK (kr)
kr in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenue      
Revenue kr 14,595 kr 8,482 kr 10,111
DARZALEX      
Revenue      
Revenue 10,056 6,135 4,419
TEPEZZA      
Revenue      
Revenue 796 593 298
Kesimpta      
Revenue      
Revenue 779 235 10
Other      
Revenue      
Revenue 41 14 14
Janssen      
Revenue      
Revenue 10,620 6,847 4,693
AbbVie      
Revenue      
Revenue 1,174 245 4,398
Roche      
Revenue      
Revenue 796 603 305
Novartis      
Revenue      
Revenue 815 236 212
BioNTech      
Revenue      
Revenue 708 416 230
Seagen      
Revenue      
Revenue 413 135 201
Other partners      
Revenue      
Revenue 69   72
Royalties      
Revenue      
Revenue 11,672 6,977 4,741
Reimbursement revenue      
Revenue      
Revenue 818 531 431
Milestone revenue      
Revenue      
Revenue 1,767 954 351
License revenue      
Revenue      
Revenue 6   kr 4,588
Collaboration revenue      
Revenue      
Revenue kr 332 kr 20